Evidence map›Paper›PMID 35806487›Full record

ReviewInternational journal of molecular sciences2022

Mamiko Takayasu, Kouichi Hirayama, Homare Shimohata, Masaki Kobayashi, Akio Koyama

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular Mechanisms of Sepsis-Associated Acute Kidney Injury.Journal of the American Society of Nephrology : JASN · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. [Nephropathology of infectious disease].Pathologie (Heidelberg, Germany) · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Editorial for theInternational journal of molecular sciences · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mamiko TakayasuDepartment of Nephrology, Tokyo Medical University Ibaraki Medical Center, Ami 300-0395, Ibaraki, Japan.
Kouichi HirayamaDepartment of Nephrology, Tokyo Medical University Ibaraki Medical Center, Ami 300-0395, Ibaraki, Japan.ORCID 0000-0003-2016-8276
Homare ShimohataDepartment of Nephrology, Tokyo Medical University Ibaraki Medical Center, Ami 300-0395, Ibaraki, Japan.
Masaki KobayashiDepartment of Nephrology, Tokyo Medical University Ibaraki Medical Center, Ami 300-0395, Ibaraki, Japan.
Akio KoyamaEmeritus Professor, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
Tokyo Medical University Ibaraki Medical Center · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 1995, when we reported the case of a patient with glomerulonephritis with IgA deposition that occurred after a methicillin-resistant

Indexed as

GlomerulonephritisGlomerulonephritis, IGAMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsHumansImmunoglobulin AStaphylococcus aureusImmunoglobulin Abacterial superantigencytokineIgA-dominant glomerulonephritispolyclonal activationrapidly progressive glomerulonephritisStaphylococcus aureusStaphylococcus infection-associated glomerulonephritisT-cell receptor

Identifiers

PMID35806487
PMCPMC9267153
OpenAlexW4283832676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.